Online Inquiry
Cat.#: ACPP-1199
| Despition | Beta crystallin S Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1654 | Human ATXN3 Protein (AC1654) | 2 µg | inquiry |
| ACPP-1091 | BMP11 Blocking Peptide (AC1091) | 250 µg | inquiry |
| ACPP-1749 | Human CSNK1D Protein (AC1749) | 5 µg | inquiry |
| ACPP-1556 | Human SMARCA4 Protein (AC1556) | 5 µg | inquiry |
| ACPP-1025 | Recombinant Human GPR56 Protein (6×His Tag) (AC1025) | 50 µg | inquiry |
| ACPP-1236 | SOX2 Blocking Peptide (AC1236) | 250 µg | inquiry |
| ACPP-1221 | Bestrophin Blocking Peptide (AC1221) | 250 µg | inquiry |
| ACPP-1548 | Human FGF 19 Protein, His (AC1548) | 5 µg | inquiry |
| ACPP-1390 | Human GDF11 Protein, His (AC1390) | 5 µg | inquiry |
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.